EDA - Risk-based PMS Plan Samples analyzed in CADC Laboratories in 2023

Sorry, this website does not support this browser

Cookies Disclaimer

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Ok

- A+
- |
- A-
- A
15301
- English
- العربية

- English
- العربية
- A+
- |
- A-
- A

Click Here
15301

Home Page
About Us
Laws, decrees, regulatory guidelines and notices
EDA publications
Media Center
The Egyptian pharmaceutical Constitution (content under construction)
Contact us
EDASPIRE
- EDASPIRE I
- EDASPIRE II
Awareness
Localization of industry
- Investor Support Service through the Central Administration for Medical Devices
Center for Continuing Professional Development (CPD)

Home Page
About Us
EDA in numbers
Laboratory testing activities metrics
Risk-based PMS Plan Samples analyzed in CADC Laboratories in 2023

Laboratory testing activities metrics

Risk-based PMS Plan Samples analyzed in CADC Laboratories in 2023

The Egyptian Drug Authority is a public service body with a legal personality affiliated with the Prime Minister. It is responsible for organizing, implementing, and monitoring the quality, effectiveness, and safety of pharmaceutical products and medical devices stipulated in the provisions of the law establishing the Authority.

About Us

About the Egyptian Drug Authority
Vision and Mission of The Egyptian Drug Authority
Establishment of the Egyptian Drug Authority
Board of Directors of the Egyptian Drug Authority
Egyptian Drug Authority’s Chairman Speech
Quality Policy and Accreditations
Services
The Central Administrations-EDA
Functions

Media Center

Events
Photo Gallery
Video Gallery
News
Announcements

Contact us

Authority headquarters: Al-Manial, Al-Agouza, Al-Haram, Al-Maadi, Al-Mansouriya.
15301
info@edaegypt.gov.eg

Find US

Copy Rights @ EDA 2021